Nephrocare Health Services Limited (NSE:NEPHROPLUS)

India · Delayed Price · Currency is INR

607.50

+22.05 (3.77%)

At close: May 22, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Providing Dialysis and Related Healthcare Services		7.56B	5.66B	4.37B	3.17B	2.84B
Providing Dialysis and Related Healthcare Services Growth		33.50%	29.47%	37.99%	11.40%	-
Total		7.56B	5.66B	4.37B	3.17B	2.84B
Total Growth		33.50%	29.47%	37.99%	11.40%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
India		5.16B	4.32B	3.86B	3.17B	2.84B
India Growth		19.46%	11.77%	21.84%	11.40%	-
Uzbekistan		733.95M	664.95M	168.50M	-	-
Uzbekistan Growth		10.38%	294.63%	-	-	-
Philippines		1.67B	681.21M	343.34M	-	-
Philippines Growth		144.48%	98.41%	-	-	-
Other Foreign Countries		3.71M	-	-	-	-
Total		7.56B	5.66B	4.37B	3.17B	2.84B
Total Growth		33.50%	29.47%	37.99%	11.40%	-

Source: S&P Global Market Intelligence.